StockData
Dolby Laboratories, Inc. logo

Dolby Laboratories, Inc. (DLB) stock

DLBNYSEPatent Owners & LessorsFiscal year ends September 27
Financials through Q3 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 30, 2026Score 18/305% above fair value
$63.61−0.98 (-1.52%)

Close on Nov 13, 2026Market cap $5.96BP/E 27.1Yield 2.08%

Dolby Laboratories cash

Cash and short-term investments held at the end of each period.

Dolby Laboratories's cash was $670.05M at Jun 26, 2026. For fiscal 2025 it was $702.60M, up 21.6% from the year before. Over ten years it grew 0.5% a year on average. The highest annual figure on record is $1.27B in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Sep 26, 2025$702.60M+21.6%
FY2024Sep 27, 2024$577.75M-39.6%
FY2023Sep 29, 2023$957.11M+17.1%
FY2022Sep 30, 2022$817.58M-35.7%
FY2021Sep 24, 2021$1.27B+12.9%
FY2020Sep 25, 2020$1.13B+21.9%
FY2019Sep 27, 2019$924.74M-16.2%
FY2018Sep 28, 2018$1.10B+25.1%
FY2017Sep 29, 2017$882.13M+37.5%
FY2016Sep 30, 2016$641.39M-4.4%
FY2015Sep 25, 2015$670.83M-16.1%
FY2014Sep 26, 2014$799.68M+34.5%
FY2013Sep 27, 2013$594.66M-25.2%
FY2012Sep 28, 2012$795.29M-15.6%
FY2011Sep 30, 2011$942.79M+11.2%
FY2010Sep 24, 2010$848.13M+15.3%
FY2009Sep 25, 2009$735.49M+86.3%
FY2008Sep 26, 2008$394.76M+7.1%
FY2007Sep 28, 2007$368.47M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 26, 2026$670.05M-11.5%
Q2 FY2026CQ1 2026Mar 27, 2026$594.74M-20.7%
Q1 FY2026CQ4 2025Dec 26, 2025$644.58M+5.4%
Q4 FY2025CQ3 2025Sep 26, 2025$702.60M+21.6%
Q3 FY2025CQ2 2025Jun 27, 2025$757.33M-16.4%
Q2 FY2025CQ1 2025Mar 28, 2025$750.34M-20.2%
Q1 FY2025CQ4 2024Dec 27, 2024$611.66M-28.0%
Q4 FY2024CQ3 2024Sep 27, 2024$577.75M-39.6%
Q3 FY2024CQ2 2024Jun 28, 2024$905.95M-1.9%
Q2 FY2024CQ1 2024Mar 29, 2024$940.22M+14.7%
Q1 FY2024CQ4 2023Dec 29, 2023$849.48M+11.1%
Q4 FY2023CQ3 2023Sep 29, 2023$957.11M+17.1%
Q3 FY2023CQ2 2023Jun 30, 2023$923.37M-9.8%
Q2 FY2023CQ1 2023Mar 31, 2023$819.81M-22.0%
Q1 FY2023CQ4 2022Dec 30, 2022$764.35M-33.2%
Q4 FY2022CQ3 2022Sep 30, 2022$817.58M-35.7%
Q3 FY2022CQ2 2022Jul 1, 2022$1.02B-19.7%
Q2 FY2022CQ1 2022Apr 1, 2022$1.05B-10.4%
Q1 FY2022CQ4 2021Dec 31, 2021$1.15B-2.3%
Q4 FY2021CQ3 2021Sep 24, 2021$1.27B+12.9%
Q3 FY2021CQ2 2021Jun 25, 2021$1.28B+21.2%
Q2 FY2021CQ1 2021Mar 26, 2021$1.17B+28.9%
Q1 FY2021CQ4 2020Dec 25, 2020$1.17B+26.9%
Q4 FY2020CQ3 2020Sep 25, 2020$1.13B+21.9%
Q3 FY2020CQ2 2020Jun 26, 2020$1.05B+24.6%
Q2 FY2020CQ1 2020Mar 27, 2020$909.30M+1.8%
Q1 FY2020CQ4 2019Dec 27, 2019$923.39M-5.3%
Q4 FY2019CQ3 2019Sep 27, 2019$924.74M-16.2%
Q3 FY2019CQ2 2019Jun 28, 2019$844.78M-18.2%
Q2 FY2019CQ1 2019Mar 29, 2019$893.55M-6.3%
Q1 FY2019CQ4 2018Dec 28, 2018$975.34M+13.9%
Q4 FY2018CQ3 2018Sep 28, 2018$1.10B+25.1%
Q3 FY2018CQ2 2018Jun 29, 2018$1.03B+22.9%
Q2 FY2018CQ1 2018Mar 30, 2018$954.10M+21.1%
Q1 FY2018CQ4 2017Dec 29, 2017$856.63M+26.4%
Q4 FY2017CQ3 2017Sep 29, 2017$882.13M+37.5%
Q3 FY2017CQ2 2017Jun 30, 2017$840.28M–
Q2 FY2017CQ1 2017Mar 31, 2017$787.61M–
Q1 FY2017CQ4 2016Dec 30, 2016$677.66M–
Q4 FY2016CQ3 2016Sep 30, 2016$641.39M–

More Dolby Laboratories figures

See a number that looks wrong?